AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17058823
Drug: Shenfu Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenfu Injection before CPB
Trial: 17058823
Drug: Shenfu Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenfu Injection after CPB
Trial: 17058823
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no Shenfu Injection)
Trial: 12730149
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of saline for 20 minutes
Trial: 12730149
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of saline
Trial: 10391422
Drug: oral microemulsion
RxNorm normalized name: cyclosporine microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral microemulsion CsA 5 mg/kg
Trial: 10391422
Drug: intravenous CsA
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: intravenous CsA 1.5 mg/kg
Trial: 1642943
Drug: Partial denitrogenation
RxNorm normalized name: rosin partially dimerized glycerol ester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partial denitrogenation by breathing oxygen from the start of injection of the induction agent
Trial: 6377970
Drug: Kallikrein 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kallikrein 600 K.U. daily for 3 months
Trial: 30917531
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 100,000 IU soft capsule (Group 1)
Trial: 30917531
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 100,000 IU oral solution in ampoule (Group 2)
Trial: 24806873
Drug: Stepwise Protocol
RxNorm normalized name: levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Stepwise Protocol of Treating Pain (individual daily pain treatment with paracetamol, extended release morphine, buprenorphine transdermal patch or pregabaline for 8 weeks)
Trial: 19050388
Drug: Drug conservation
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug conservation (episodic use of antiretroviral therapy guided by CD4 cell count)
Trial: 19050388
Drug: Viral suppression
RxNorm normalized name: Buckley's Cough Suppressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viral suppression (continuous antiretroviral therapy)
Trial: 27432436
Drug: Inactivated FVRCP
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated FVRCP vaccine
Trial: 27432436
Drug: Modified live
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified live FVRCP vaccine
Trial: 19548437
Drug: Combined hormonotherapy
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined hormonotherapy with Chinese drugs for detoxifying
Trial: 16426798
Drug: Haptotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haptotherapy treatment (5 sessions of 45 minutes each)
Trial: 14707013
Drug: High exercise
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High exercise level (Hex; approximately 4 MJ/day) with high-fat diet (HF; 50% of energy, 700 kJ/100 g)
Trial: 14707013
Drug: High exercise
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High exercise level (Hex; approximately 4 MJ/day) with low-fat diet (LF; 20% of energy, 300 kJ/100 g)
Trial: 14707013
Drug: No exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No exercise (Nex; control) with high-fat diet (HF; 50% of energy, 700 kJ/100 g)
Trial: 14707013
Drug: No exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No exercise (Nex; control) with low-fat diet (LF; 20% of energy, 300 kJ/100 g)
Trial: 14707013
Drug: High-fat diet
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat diet (HF; 50% of energy, 700 kJ/100 g)
Trial: 14707013
Drug: Low-fat diet
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat diet (LF; 20% of energy, 300 kJ/100 g)
Trial: 6285406
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg CBD
Trial: 28793785
Drug: Pictorial aid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pictorial aid intervention (photographic representation of medications, indications, and dosing schedule)
Trial: 28793785
Drug: Standard clinic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard clinic visit discharge medication list (control)
Trial: 24194508
Drug: Exenatide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide (10 μg four times a day)
Trial: 15929052
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of 1 x 10(8) autologous MSCs (n = 5)
Trial: 10102961
Drug: Ranitidine bismuth
RxNorm normalized name: RANITIDINE BISMUTH CITRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine bismuth citrate 400 mg, metronidazole 500 mg, and clarithromycin 500 mg, all twice daily for 1 week (RMC)
Trial: 10102961
Drug: Amoxycillin 1000
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 1000 mg substituted for clarithromycin (RMA)
Trial: 7572746
Drug: Soy formula
RxNorm normalized name: Nursoy Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy formula with ascorbic acid at 625 mumol/L (110 mg/L)
Trial: 7572746
Drug: Soy formula
RxNorm normalized name: Nursoy Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy formula with ascorbic acid at 1250 mumol/L (220 mg/L)
Trial: 2405811
Drug: Isokinetic concentric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isokinetic concentric training on a Cybex II+ isokinetic dynamometer, three days weekly for six weeks, five sets of ten maximal effort knee extensions at 1.05 rad/s
Trial: 7441660
Drug: naproxen (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naproxen (750 mg/d)
Trial: 7441660
Drug: indomethacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: indomethacin (100 mg/d)
Trial: 31773764
Drug: Oral antiglycemic
RxNorm normalized name: ANTILIPEMIC AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antiglycemic medication and insulin
Trial: 30907034
Drug: FMPBE (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FMPBE (250 mg/day, n = 21)
Trial: 30907034
Drug: Placebo (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (250 mg starch/day, n = 19)
Trial: 29084159
Drug: Association with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Association with monthly living expenses
Trial: 26030346
Drug: Oral testosterone
RxNorm normalized name: testosterone Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral testosterone undecanoate 80 mg/day
Trial: 26030346
Drug: Oral testosterone
RxNorm normalized name: testosterone Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral testosterone undecanoate 160 mg/day
Trial: 26030346
Drug: Oral testosterone
RxNorm normalized name: testosterone Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral testosterone undecanoate 240 mg/day
Trial: 19836748
Drug: Flat patch
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flat patch mesh
Trial: 19836748
Drug: Double-sided patch
RxNorm normalized name: cured fat, pork side bacon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-sided patch
Trial: 17691589
Drug: Fe-59 labeled
RxNorm normalized name: Fe
DrugBank: Ferric cation (DB13949)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fe-59 labeled iron(III)-hydroxide polymaltose complex (IPC, Maltofer), 100 mg elemental iron
Trial: 17691589
Drug: Fe-59 labeled
RxNorm normalized name: Fe
DrugBank: Ferric cation (DB13949)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fe-59 labeled iron(III)-hydroxide polymaltose complex (IPC, Maltofer) combined with 600 mg aluminium hydroxide (10 ml)
Trial: 15761783
Drug: N-acetylcysteine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (600 mg bid)
Trial: 15761783
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (500 mg bid)
Trial: 15761783
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of N-acetylcysteine and Vitamin C (600 mg NAC and 500 mg Vitamin C bid)
Trial: 15761783
Drug: N-acetylcysteine, Vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine, Vitamin C, and NAC/Vitamin C combination
Trial: 10421142
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g of sulbactam plus ampicillin (group 1)
Trial: 10421142
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of cefazolin (group 2)
Trial: 8889287
Drug: Control (neuroleptic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (neuroleptic drugs)
Trial: 26427987
Drug: Trabeculectomy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trabeculectomy with combined application of MMC (0.4 mg/ml for 3 min) and bevacizumab (2.5 mg in 0.2 ml)
Trial: 26427987
Drug: Trabeculectomy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trabeculectomy with application of MMC (0.4 mg/ml for 3 min) only
Trial: 22119634
Drug: Intrathecal hyperbaric
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal hyperbaric bupivacaine 15 mg (Group B)
Trial: 22119634
Drug: Hyperbaric bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric bupivacaine 12 mg with fentanyl 15 μg (Group BF)
Trial: 19221727
Drug: Silymarin 140
RxNorm normalized name: silymarin 140 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin 140 mg three times daily for 14 days
Trial: 18372698
Drug: Nutrition (Nut:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition (Nut: daily protein supplement)
Trial: 9541719
Drug: Troglitazone (200-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone (200-600 mg once daily)
Trial: 9541719
Drug: Troglitazone added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone added to sulfonylureas or insulin
Trial: 2114133
Drug: General practitioners
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General practitioners receiving extended waiting time information for hospital consultation and treatment in general surgery.
Trial: 380952
Drug: 1% (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% (2.5 mg) reproterol aerosol
Trial: 380952
Drug: 2% (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% (5 mg) reproterol aerosol
Trial: 25835492
Drug: Vitamin D3,
RxNorm normalized name: Vitamin D3, 25 mcg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3, 30000 IU given orally once weekly for 8 weeks
Trial: 19236467
Drug: Ginsenoside-Rd 10
RxNorm normalized name: ginsenoside
DrugBank: Ginsenosides (DB14152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginsenoside-Rd 10 mg (group A)
Trial: 19236467
Drug: Ginsenoside-Rd 20
RxNorm normalized name: ginsenoside
DrugBank: Ginsenosides (DB14152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginsenoside-Rd 20 mg (group C)
Trial: 19236467
Drug: Ginsenoside-Rd (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginsenoside-Rd (both doses)
Trial: 17958849
Drug: Polyphenon E
RxNorm normalized name: Polyphenon E
DrugBank: Sinecatechins (DB01266)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Polyphenon E 15% Ointment
Trial: 17958849
Drug: Polyphenon E
RxNorm normalized name: Polyphenon E
DrugBank: Sinecatechins (DB01266)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Polyphenon E 10% Cream
Trial: 15493847
Drug: Domestic octreotide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domestic octreotide injection (200 microg, intramuscular)
Trial: 15493847
Drug: Imported octreotide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imported octreotide injection (200 microg, intramuscular)
Trial: 15493847
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of domestic and imported octreotide injections
Trial: 7944845
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy in hospitals with coronary revascularization services
Trial: 7944845
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy in small hospitals with coronary revascularization facilities
Trial: 7944845
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy in hospitals without coronary revascularization services
Trial: 7944845
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy in smaller hospitals
Trial: 3308186
Drug: 0.01 mg
RxNorm normalized name: urea 0.01 MG/MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01 mg daily
Trial: 3308186
Drug: 0.03 mg
RxNorm normalized name: biotin 0.03 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.03 mg daily
Trial: 3308186
Drug: 0.06 mg
RxNorm normalized name: urea 0.06 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.06 mg daily
Trial: 20852871
Drug: Rosuvastatin 20
RxNorm normalized name: rosuvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 20 mg once daily for 6 weeks
Trial: 19014770
Drug: Budesonide (inhaled),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (inhaled), administered twice daily
Trial: 19014770
Drug: Bronchodilator (albuterol)
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchodilator (albuterol)
Trial: 19014770
Drug: Placebo (inhaled)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (inhaled)
Trial: 14567121
Drug: Transdermal 17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17 beta‐estradiol gel (1.5 mg/day) plus nomegestrol acetate (5 mg/day)
Trial: 14567121
Drug: Oral equine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral equine sulfoconjugated estrogen (0.625 mg/day) plus nomegestrol acetate (5 mg/day)
Trial: 2681331
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) 3.2 mg per day
Trial: 2681331
Drug: Prednisone (PRED)
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone (PRED) 40 mg per day
Trial: 2681331
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) 2.0 mg per day
Trial: 2681331
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) ≥ 1.84 mg/day/70 kg
Trial: 2681331
Drug: Prednisone (PRED)
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone (PRED) ≥ 15 mg per day
Trial: 57959
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release decongestant combination
Trial: 57959
Drug: Full triple-drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full triple-drug capsule
Trial: 28270380
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of vital signs with a robust algorithm based on machine learning
Trial: 26387946
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of endocrine therapy with targeting JAG1-NOTCH4
Trial: 23750462
Drug: CBASP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBASP plus antidepressant medication
Trial: 21852067
Drug: Wavefront-optimized PRK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wavefront-optimized PRK (Allegretto Wave Eye‐Q software version 2.020 default treatment)
Trial: 17920505
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of oral ibuprofen
Trial: 17920505
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of oral paracetamol
Trial: 11574180
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg 17beta‐estradiol/0.15 mg desogestrel (n=53)
Trial: 11574180
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg conjugated estrogens/0.15 mg norgestrel (n=36)
Trial: 9623427
Drug: 0.5% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% bupivacaine 75 mg (group A; n = 15)
Trial: 9623427
Drug: 0.5% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% bupivacaine 75 mg‐ketamine 0.3 mg kg‐1 (group B; n = 14)
Trial: 9623427
Drug: 0.5% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% bupivacaine 75 mg‐ketamine 0.5 mg kg‐1 (group C; n = 5)
Trial: 9623427
Drug: 0.5% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% bupivacaine 75 mg‐ketamine 0.67 mg kg‐1 (group D; n = 15)
Trial: 7836627
Drug: 142 mg
RxNorm normalized name: phentermine 142 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 142 mg Zn as Zn sulfate (ZnSO4) during Ca intakes of 230, 500 and 800 mg/day
Trial: 7836627
Drug: 142 mg
RxNorm normalized name: phentermine 142 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 142 mg Zn as Zn sulfate (ZnSO4)
Trial: 31795895
Drug: Endovascular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular treatment in MR CLEAN trial
Trial: 31795895
Drug: Endovascular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular treatment in IMS III trial
Trial: 29209514
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (6 capsules of 1g daily, totaling 3.6g LCn-3PUFA)
Trial: 16884779
Drug: Topical cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclosporine 0.05% 4 times a day
Trial: 16884779
Drug: Topical cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclosporine 0.05% with pulsed prednisolone acetate 1% dosing
Trial: 16884779
Drug: Historical control
RxNorm normalized name: typhus, historical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Historical control subjects using topical steroids
Trial: 10322817
Drug: Huoxue Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Huoxue Tablet
Trial: 12585189
Drug: Composite Danshen
RxNorm normalized name: DANSHEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Composite Danshen tablet
Trial: 8110625
Drug: Defibrotide (group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Defibrotide (group D): day 0, 3.6 g by intravenous infusion in 12 hours; days +1 to +6, 800 mg tid intravenously; days +7 to +10/+12, 400 mg tid intramuscularly
Trial: 8110625
Drug: Heparin (group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (group H): day 0, 1000 IU/hour infused over 12 hours; days +1 to +10/+12, 5000 IU tid subcutaneously
Trial: 8110625
Drug: Heparin (group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (group H)
Trial: 3314717
Drug: 2% to
RxNorm normalized name: A/T/S 2% Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% to 3% topical minoxidil solution
Trial: 3314717
Drug: 3% topical
RxNorm normalized name: Triaz 3% Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% topical minoxidil solution
Trial: 27974311
Drug: Intensive medical
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive medical nutrition therapy with energy intakes at nationally recommended amounts
Trial: 21072684
Drug: IMSI (Intracytoplasmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMSI (Intracytoplasmic Morphologically Selected Sperm Injection)
Trial: 15136972
Drug: L-arginine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (200 mg/kg) after treatment with ramipril (5 mg/day)
Trial: 15136972
Drug: L-arginine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (200 mg/kg) after treatment with losartan (50 mg/day)
Trial: 15136972
Drug: L-arginine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine alone
Trial: 15136972
Drug: L-arginine after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine after treatment with ramipril or losartan
Trial: 11591569
Drug: ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ipratropium bromide inhalation aerosol, 42 microg